Regenacy Pharmaceuticals Provides Healthcare Services.
Regenacy Pharmaceuticals has raised $9.3M in total funding. The most recent round was Series B. The last funding was announced in August 2022.
Regenacy Pharmaceuticals's investors include Taiwania Capital Management Corporation, 3E Bioventures, Viva Biotech, Rivas Capital, Yonjin Venture.
Regenacy Pharmaceuticals is headquartered in Waltham, United States.
Regenacy Pharmaceuticals Provides Healthcare Services.
Regenacy Pharmaceuticals is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Regenacy Pharmaceuticals — Funding & Investors." VCBacked, August 15, 2022, https://www.vcbacked.co/company/regenacy-pharmaceuticals. Accessed September 30, 2026.
VCBacked. (2022). Regenacy Pharmaceuticals — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/regenacy-pharmaceuticals
{{cite web |title=Regenacy Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/regenacy-pharmaceuticals |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated